A new trading day began on Friday, with Zai Lab Limited ADR (NASDAQ: ZLAB) stock price down -6.00% from the previous day of trading, before settling in for the closing price of $37.33. ZLAB’s price has ranged from $13.48 to $39.61 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 118.89% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 43.70%. With a float of $108.11 million, this company’s outstanding shares have now reached $109.14 million.
In an organization with 1869 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 62.94%, operating margin of -70.71%, and the pretax margin is -64.44%.
Zai Lab Limited ADR (ZLAB) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Zai Lab Limited ADR is 0.94%, while institutional ownership is 51.11%. The most recent insider transaction that took place on Mar 17 ’25, was worth 115,230. In this transaction an insider of this company sold 3,000 shares at a rate of $38.41, taking the stock ownership to the 30,834 shares. Before that another transaction happened on Mar 17 ’25, when Company’s Officer proposed sale 3,000 for $38.41, making the entire transaction worth $115,230.
Zai Lab Limited ADR (ZLAB) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 43.70% per share during the next fiscal year.
Zai Lab Limited ADR (NASDAQ: ZLAB) Trading Performance Indicators
Here are Zai Lab Limited ADR’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.38. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.60.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.60, a number that is poised to hit -0.46 in the next quarter and is forecasted to reach 0.24 in one year’s time.
Technical Analysis of Zai Lab Limited ADR (ZLAB)
Let’s dig in a bit further. During the last 5-days, its volume was 0.68 million. That was inferior than the volume of 0.89 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 46.85%. Additionally, its Average True Range was 1.87.
During the past 100 days, Zai Lab Limited ADR’s (ZLAB) raw stochastic average was set at 71.37%, which indicates a significant increase from 43.85% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 57.64% in the past 14 days, which was higher than the 52.93% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $30.59, while its 200-day Moving Average is $24.79. However, in the short run, Zai Lab Limited ADR’s stock first resistance to watch stands at $35.71. Second resistance stands at $36.32. The third major resistance level sits at $36.84. If the price goes on to break the first support level at $34.57, it is likely to go to the next support level at $34.05. Assuming the price breaks the second support level, the third support level stands at $33.43.
Zai Lab Limited ADR (NASDAQ: ZLAB) Key Stats
With a market capitalization of 3.83 billion, the company has a total of 109,628K Shares Outstanding. Currently, annual sales are 398,990 K while annual income is -257,100 K. The company’s previous quarter sales were 109,070 K while its latest quarter income was -81,680 K.
